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Abstract Metabolic adaptation to a disturbance of
homeostasis is determined by a series of interconnected
physiological processes and molecular mechanisms that
can be followed in space (i.e., different organs or organ-
elles) and in time. The amplitudes of these responses of this
‘‘systems flexibility network’’ determine to what extent the
individual can adequately react to external challenges of
varying nature and thus determine the individual’s health
status and disease predisposition. Connected pathways and
regulatory networks act as ‘‘adaptive response systems’’
with metabolic and inflammatory processes as a core—but
embedded into psycho-neuro-endocrine control mecha-
nisms that in their totality define the phenotypic flexibility
in an individual. Optimal metabolic health is thus the
orchestration of all mechanisms and processes that main-
tain this flexibility in an organism as a phenotype. Con-
sequently, onset of many chronic metabolic diseases results
from impairment or even loss of flexibility in parts of the
system. This also means that metabolic diseases need to be
diagnosed and treated from a systems perspective referring
to a ‘‘systems medicine’’ approach. This requires a far
better understanding of the mechanisms involved in
maintaining, optimizing and restoring phenotypic flexibil-
ity. Although a loss of flexibility in a specific part of the
network may promote pathologies, this not necessarily
takes place in the same part because the system compen-
sates. Diagnosis at systems level therefore needs the
quantification of the response reactions of all relevant parts
of the phenotypic flexibility system. This can be achieved
by disturbing the homeostatic system by any challenge
from extended fasting, to intensive exercise or a caloric
overload.
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Introduction
Physiology maintains a well-orchestrated machinery
allowing the organism to adapt to the continuously
changing environment, of which food takes a major share.
We term this organism response capacity ‘‘phenotypic
flexibility’’ and this is from our understanding central for
overall homeostasis and thus for a healthy life. Processes
and mechanisms forming the basis of phenotypic flexibility
include substrate fluxes for ATP production and biosyn-
thesis, oxidative stress and inflammatory responses,
immune functions as well as DNA repair, apoptosis and
others. All of these processes involve multiple molecular
mechanisms, interconnected and coordinated by complex
regulatory networks which need a real systems approach
for the most comprehensive description and in-depth
understanding.
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Daily meals provide energy pulses which are efficiently
absorbed and distributed for immediate needs in ATP
production or stored as glycogen or lipids. Possible side
effects of these energy pulses are oxidative and inflam-
matory responses that are ideally quenched by counter-
acting mechanisms. Stress reactions on the other side
require the immediate mobilization of endogenous energy
resources with changes in substrate flow for the metabolic
needs. Chronic stress conditions may induce adaptation
processes that go beyond the limits of normal phenotypic
flexibility leading to progressive inflexibility, which in turn
contributes to a disease onset. Food components, by excess
or by lack in the diet, challenge phenotypic flexibility:
Essential nutrients and other food bioactives, when con-
sumed appropriately, play key roles in the mechanisms that
maintain phenotypic flexibility, for example as cofactors,
while excess of energy, high glucose and fructose intakes
or certain trans-fatty acids cause a decline in phenotypic
flexibility.
The importance of maintaining flexibility as a key fea-
ture to optimal health calls for new research on the rela-
tionship between nutrition and health and in particular with
the identification of valid ‘‘biomarkers of health,’’ related
to the dynamics of regulatory processes. These markers
may be found by exploiting the processes and quantify the
response reactions to a stress challenge including a ‘‘die-
tary stress’’ (van Ommen et al. 2008, 2009).
The key example for the loss of phenotypic flexibility is
the development of type 2 diabetes with the impaired
response to insulin secretion. It usually takes years from an
initial impairment of insulin action in peripheral tissues and
liver with hyperglycemia, hyperinsulinemia to a progres-
sive loss of b-cell responsiveness and finally complete loss
of b-cell mass. Proper diagnosis of phenotypic flexibility in
this context can be made by analyzing all relevant changes
in accessible compartments (plasma, exhaled air, urine)
during an oral glucose tolerance test (OGTT) and define the
amplitude of the changes over time in healthy individuals
and those with insulin resistance or diabetes (Ho et al.
2013). But this example also illustrates the complex nature
of the phenotypic flexibility concept. Hepatic insulin
resistance may be caused by fatty liver as a result of adi-
pose tissue insulin resistance with a limited capacity of
adipocytes to take up glucose for conversion into fatty
acids and triglycerides (Virtue and Vidal-Puig 2010). But
hepatic lipid accumulation may also be caused by a
reduced biosynthesis of phosphatidylcholine that is needed
for export of the lipids via VLDL and/or by an impaired
hepatic fatty acid oxidation (Vance 2013). In view of other
dietary determinants, a high fructose intake also increases
hepatic de novo fatty acid biosynthesis and the develop-
ment of non-alcoholic fatty liver disease. In contrast to
liver, insulin resistance in peripheral tissues is not only
caused by lipotoxicity but most likely also involves, in a
causative manner, alterations in amino acid homeostasis—
mainly of the branched chain amino acids—and overall
protein homeostasis.
Phenotypic flexibility presents a systems view on the
complete molecular and physiological ‘‘machinery’’ of
stress responses related to metabolic and caloric challenges
(Fig. 1). The paragraphs below illustrate the concept of
phenotypic flexibility by describing the human phenotypic
responses to the three macronutrients glucose, triglycerides
and proteins. Together, these examples span from intra-
cellular regulatory mechanisms to whole-body physiology
and show the complexity and the need for a systems
approach in studying phenotypic flexibility and its appli-
cation in metabolic health research and systems healthcare.
Phenotypic flexibility responses to a glucose challenge
The signaling compensatory response on glucose
Our metabolic system appears not ‘designed’ to deal with
large amounts of simple carbohydrate, although dietary
intake of large quantities of complex carbohydrates (starch)
has been part of human diets throughout recent evolution.
Except for some fruits and honey delivering mono and
disaccharides in early phases of human evolution, regular
consumption of higher amounts of mono- and disaccha-
rides with foods and beverages has become prevalent only
in the last few decades. Glucose release from complex
carbohydrates such as starch is rate limiting primarily
because hydrolysis of glucosidic bonds occurs in the upper
small intestine by pancreatic amylase. In contrast, admin-
istration of 75 g of D-glucose as during a standard OGTT
causes an immediate increase in plasma glucose levels and
triggers a large array of compensatory mechanisms. Gas-
trointestinal hormones such as CCK (Geneontology), GI,
GLP1 and PYY increase in response to OGTT (Blaak et al.
2012), which may reflect an ‘‘archaic response’’ of the
gastrointestinal tract to a complex meal containing fat,
carbohydrates and proteins rather than the artificial condi-
tion of an isolated nutrient such as glucose entering the
system. Increased plasma glucose, together with the ele-
vated levels of the incretins GIP and GLP1, causes insulin
and C-peptide secretion from pancreatic b-cells and a
modest inhibition of glucagon secretion from a-cells.
Insulin controls glucose disposition in muscle and adipose
tissue by recruitment of the glucose transporter GLUT4
into the plasma membrane. The presence of additional
GLUT4 allows increased glucose uptake. In the liver, the
additional glucose induces glycogen production by
changing the activity states of glycogen synthase and
phosphorylase downstream of the insulin receptor.
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The metabolic systems response to glucose
Among the most responsive metabolites that increase in
plasma after an OGTT are surprisingly primary and sec-
ondary bile acids that increase up to 8-fold in concentration
compared to fasting (Shaham et al. 2008). Increased bile
acid secretion into the gut and rapid absorption into the
circulation may be due to the emptying of the gallbladder
caused by CCK that is induced by glucose intake. Bile acid
stimulation of the TGR5 bile acid receptor and the farne-
soid receptor (FXR) in liver may control a variety of
metabolic processes that relate to energy expenditure and
to plasma triglyceride and cholesterol levels. About 10
different amino acids (branched chain, aromatic and non-
proteinogenic amino acids) decline significantly following
insulin secretion. They remain below initial levels for more
than 2 h although glucose and insulin levels have already
returned to baseline. The molecular mechanisms underly-
ing these changes are the insulin-dependent recruitment of
amino acid transporters to the plasma membrane (of mus-
cle) allowing increased amino acid delivery to oxidation or
to protein synthesis which depends on insulin receptor and
mTOR activation. Interestingly, almost all the amino acids
that show decreased plasma levels in response to OGTT
have been identified in cohort studies as ‘‘marker metab-
olites’’ of insulin resistance and type 2 diabetes mellitus
with increased levels in fasting state (Newgard et al. 2009).
Others have associated changes in plasma levels of some of
these amino acids as predictive for disease development.
This emphasizes the key role of insulin not only in glucose
handling but also in amino acid metabolism.
The OGTT in addition causes a suppression of lipolysis
that in turn reduces plasma non-esterified fatty acids
(NEFA) and ketone body concentrations. Elevated levels of
those metabolites in fasting blood also characterize an
insulin-resistant state and type 2 diabetes. Interestingly,
there are also significant reductions in plasma acyl-carni-
tine levels, while free carnitine increases (Krug et al.
2012). Since acyl-carnitines are the products of mito-
chondrial b-oxidation, these changes in plasma during the
OGTT demonstrate the shift from utilization of fatty acids
as prime energy substrates during fasting to glucose
Fig. 1 Main processes and events involved in (decrease of) pheno-
typic flexibility and the resulting (patho-)physiological consequences
(adapted from Lusis et al. 2008). Multiple organs and processes are
involved in maintaining homeostasis in aspects of metabolism, all of
them are interacting with each other and most of them are reversible
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utilization following the OGTT. After at least 3 h, plasma
levels of all measured metabolites have returned to baseline
and a steady increase in plasma NEFA, ketone bodies, and
amino acid levels occurs again. Those changes, however,
are delayed in humans with hyperinsulinemia and insulin
resistance indicating a prolonged stay in an anabolic state.
In this respect, the delay in clearance of plasma glucose is
associated with a delayed return of catabolic marker
metabolites to initial values. These changes in plasma
metabolite patterns occur in essentially all major metabolic
pathways of macronutrient metabolism (glucose, fatty
acids, amino acids). Since the release and uptake of these
metabolites by organs depend on insulin sensitivity, the
OGTT seems particularly suitable to assess phenotypic
flexibility of individuals in time-dependence and in organ
specificity (Fig. 2).
Fasting and flexibility
In contrast to the postprandial state, fasting is characterized
by a flow of free fatty acids from adipose tissue to muscle
and liver, an increase in hepatic ketone body production,
and a release of amino acids into circulation mainly for use
in hepatic gluconeogenesis. The OGTT, usually performed
after an overnight fasting period, reverses these processes
within 15–30 min. The time-dependent response and return
to homeostasis to an OGTT thus may be taken as a measure
of the individual’s flexibility to switch from a catabolic to
an anabolic state. Recent studies employing plasma
metabolite profiling during the fasting state (Lawton et al.
2008) and after an OGTT in humans (Shaham et al. 2008;
Wopereis et al. 2009; Zhao et al. 2009; Spe´gel et al. 2009;
Ho et al. 2013; Krug et al. 2012) have revealed major
changes in numerous plasma metabolites that go far
beyond the well-known changes in plasma glucose and
insulin or NEFA levels.
Phenotypic flexibility responses to triglyceride
challenges
The liver as gatekeeper in a triglyceride challenge
The hydrolysis of triglycerides in the intestinal lumen and
absorption of the constituents is efficient. Lipids are
assembled into chylomicrons with the help of apolipopro-
teins synthesized in epithelial cells and are released into
lymph. Because the intestine expresses many enzymes that
control mitochondrial, peroxisomal and microsomal oxi-
dation, fatty acids can also be utilized by the enterocyte.
Fatty acids play an important role as signaling molecules in
the regulation of their own metabolism. The transcription
factor PPARa, a member of the superfamily of nuclear
receptors, plays an essential role in this regulation. The
liver is the master gatekeeper of ingested and de novo
synthesized lipids, with far greater capacity than the
Fig. 2 Whole-body metabolic condition and control circuits charac-
terizing a catabolic (fasting) as compared to anabolic/postprandial
state with major changes in hormone and metabolite levels which
define the etches of a metabolic space and in their time-dependence
also serve as a measure of phenotypic flexibility
423 Page 4 of 9 Genes Nutr (2014) 9:423
123
intestine for storage and maintenance of lipid homeostasis
during the transition from fed to fasted states. Both organs,
through the assembly and secretion of lipid-containing
particles, deliver lipids in the form of lipoproteins to
peripheral tissues and cycle between postprandial and
postabsorptive states. Oral fat challenges showed dramatic
inter-individual differences between the metabolism of
triglyceride-rich lipoproteins, attributed to age, sex, genetic
factors but also to the characteristic of the fat load or the
background diet (Fielding 2011).
Plasma clearance as flexibility parameter
Importantly, the observed associations between postpran-
dial lipemia-related variables and CVD risk are not pri-
marily due to the levels of chylomicrons released by the gut
into the circulation, but rather to the levels of chylomicron
remnants remaining in circulation following the fat load
and the time required for their total clearance. Apparently,
the capacity (flexibility) of the system to return to equi-
librium after a metabolic challenge is more relevant to
health than the actual deviation from the steady state.
Therefore, an impaired catabolism of chylomicron rem-
nants may represent early changes in phenotypic flexibility
given their association with cardiovascular disease risk
(Chan et al. 2013; Mihas et al. 2011). Besides the mea-
surement of chylomicron remnants or APOB48 (Fujioka
and Ishikawa 2009), more recent studies have described the
time courses of plasma metabolites and proteins upon
different scenarios involving dietary challenges (Beaudoin
et al. 2011). However, the relation between traditional and
novel biomarkers has not been established.
Adipose expandability
Following the packaging of dietary fat into chylomicrons
and release into lymph, a key tissue for its disposal is
adipose tissue and a fundamental element in phenotypic
flexibility of the adipose tissue is its expandability. The
failure in proper adipose tissue expansion rather than
obesity per se is a key factor by which a positive energy
balance is linked to type 2 diabetes as well as other met-
abolic diseases (Virtue and Vidal-Puig 2010; Medina-Go-
mez et al. 2007). Once the individual’s capacity to store
additional fat in the adipocyte is reached, lipids begin to
accumulate in other tissues such as liver and muscle
leading to harmful consequences (Virtue and Vidal-Puig
2010).
Circadian rythm
The circadian rhythm is one of the best established
mechanisms of phenotypic flexibility that has been
ingrained in all living things in order to maintain syn-
chronicity with the pace defined by the rotation of the Earth
around its axis. Based on data from studies determining the
circadian metabolomic changes, it has become evident that
the lipid metabolome is among the most modulated path-
ways, underscoring the importance of lipid metabolism,
including dietary fat and relevance of maintaining this
pathway attuned with the environmental changes driven by
the daily rhythms of nature. (Eckel-Mahan et al. 2012;
Dallmann et al. 2012).
The inflammatory response
A postprandial inflammatory response to triglicerides
(Giuseppe Derosa et al. 2009) but also to glucose (Derosa
et al. 2010) or a mixed meal challenge has been described.
Yet, a thorough nutrigenomic examination of the inflam-
matory response resulted in only subtle and minor effects
(Pellis et al. 2011; Wopereis et al. 2013). Apparently, in
healthy subjects, phenotypic flexibility mechanisms pre-
vent the onset of a strong inflammatory reaction. Interest-
ingly, many studies reporting on a postprandial
inflammatory response had no proper control group, con-
founding the conclusions (for a discussion see (Wopereis
et al. 2013). Yet, this area needs further attention, as many
relevant but controversial mechanisms have been identified
in animal models but still need to be validated for human
translation, such as lipid-based leaky gut systemic LPS
inflammation (Liang et al. 2014), differences between
saturated and unsaturated hepatic inflammation triggers
(Lichtenstein et al. 2010). Obviously, chronic caloric
overload produces a metabolic-inflammatory response of
which the mechanisms are being unraveled (Osborn and
Olefsky 2012), but the acute inflammatory response needs
further attention as the molecular tools to study this
become available.
Phenotypic flexibility responses to protein challenges
The importance of amino acid homeostatic control
Dietary protein intake has been fundamentally important
for the development of the human species because the
amino acid substrates for protein synthesis do not have to
be synthesized de novo. Increased protein intake not only
allowed the body length to increase in human evolution but
was also a key determinant in brain development (Laus
et al. 2011). Yet, as protein synthesis cannot be increased
infinitely, the current luxury supply of dietary protein
requires that substantial quantities of amino acids are oxi-
dized and used as energy substrates. Amino acids con-
tribute on average with 15 to 20 % to fuel oxidation.
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However, a consequence of amino acid oxidation is the
increased release of ammonia which needs to be detoxified
by the hepatic urea cycle followed by elimination through
the kidneys. In addition, the surplus of methionine and
cysteine in the diet provided in larger quantities with ani-
mal protein sources increases of sulfate excretion via kid-
ney with net effects on extracellular acidification and
increased renal acid elimination. The daily turnover of
amino acids exceeds that of lipids by around 30 % and is
almost two-fold higher than that of glucose.
Plasma homeostasis of amino acids is most important
because numerous individual amino acids have distinct
metabolic roles such as neurotransmitters (i.e., glutamate,
glycine) or precursors thereof (GABA from glutamate, or
catecholamines from tyrosine) or contribute to a variety of
synthetic pathways or other regulatory processes. A prime
example is nitric oxide (NO) which is derived from argi-
nine and acts as a signaling molecule in numerous pro-
cesses (Hoang et al. 2013). It has been proposed that
dietary arginine is converted into citrulline in the intestine
which prevents arginine plasma levels to overshoot in the
absorptive phase which would lead to an increased NO
production with numerous downstream effects for example
on the vasculature (Kaore et al. 2013). Only small quan-
tities of portal blood citrulline are taken up during liver
passage, but the kidney extracts most citrulline and con-
verts it back to arginine. Liver extraction of other amino
acids delivered through portal blood is substantial with the
exception of the branched chain and aromatic amino acids
that consequently show the most impressive increases in
peripheral blood after protein intake.
Signaling control of amino acid homeostasis
Amino acid homeostasis is thus tightly regulated at all
levels (absorptive, anabolic, catabolic, protein synthesis or
degradation). Protein turnover as the sum of degradation
and synthesis is subject to regulation by numerous hor-
mones. Insulin reduces protein breakdown and promotes
protein synthesis when plasma insulin levels rise and
amino acid levels also increase following protein intake.
Under these conditions, insulin has the strongest effects on
protein balance compared to all other hormones including
growth hormone/IGF, epinephrine, testosterone or thyroid
hormones. In contrast to insulin, stress hormones such as
glucagon, glucocorticoids and catecholamines strongly
increase protein breakdown but seem also to be able to
modestly increase protein synthesis rate.
In contrast to carbohydrate-rich meals, protein-rich
meals cause glucagon secretion, which also occurs in the
presence of dietary carbohydrates with a simultaneous
increase in plasma insulin. Although some amino acids can
effectively elicit insulin secretion (for example arginine),
the totality of circulating amino acids in the absorptive
phase promotes a substantial glucagon release. This
counteracting effect of amino acid on insulin secretion
prevents a hypoglycemia during high protein, but low
carbohydrate intake. Glucagon increases hepatic gluco-
neogenesis from amino acids allowing under high protein
intake the maintenance of plasma glucose levels and
reserves of glycogen. Yet, the clearance of the amino acids
from plasma in the postprandial state is increased in the
presence of insulin. In diabetes, removal of amino acids
from plasma seems delayed and gluconeogenesis from
amino acids in liver seems enhanced by the lack of proper
suppression by insulin, thus contributing to hyperglycemia.
In view of the effects of insulin on protein synthesis in the
presence of elevated plasma amino acids during high pro-
tein intake, the concerted action of the insulin and mTOR
signaling comes into play. mTOR comprises two protein
complexes TORC1 and TORC2. mTORC1 (mammalian
TORC1) functions as an environmental sensor to promote
anabolic and inhibit catabolic cellular functions. It phos-
phorylates and activates protein kinases S6K1 and S6K2
with the substrate ribosomal protein S6, a component of the
40S ribosome and of 4E-BP1 promoting ribosome genesis
and protein synthesis. Intracellular amino acids and among
them leucine are sensed by GTPases and activate
mTORC1. The downstream target of the insulin receptor
signaling pathway Akt inhibits the TSC2 protein and
allows Rheb-GTP to accumulate and to activate mTORC1
and thus amplifies the amino acid dependent activation. On
the other hand, AMP-kinase is a sensor of the cellular
energy status and exerts inhibitory effects on the mTOR
system. Interestingly, exercise also enhances mTOR
activity and thus promotes metabolic adaptation to nutri-
ents and exercise in skeletal muscle. However, mTORC1
signaling can attenuate Akt activation through a negative
feedback mechanism. Inhibitory phosphorylation of the
insulin receptor substrate 1 and the mTORC2 component
Rictor by mTORC1 and S6-kinase suppresses the ability of
insulin to stimulate Akt as a key effector of insulin sig-
naling. Amino acid induced mTORC1 signaling can
decrease insulin sensitivity, and this can be observed in all
metabolically important tissues examined. In this respect, it
is not surprising that amino acid homeostasis is impaired in
humans with the metabolic syndrome. That obesity affects
amino acid metabolism is known since 1969 when it was
first described that plasma levels of branched chain amino
acids (BCAA) are elevated in obesity (Felig et al. 1969). It
was recently shown that these changes in plasma BCAA
are also found in obese children and that they predict future
development of insulin resistance (McCormack et al.
2013). Numerous studies employing metabolite profiling in
insulin-resistant humans or patients with type 2 diabetes
(fasting plasma) have identified predominantly amino acids
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such as the BCAA and their degradation products (New-
gard et al. 2009), glycine, citrulline and proline but also
aminoadipic acid from lysine degradation as marker
metabolites (Menni et al. 2013). However, there are cur-
rently no studies that demonstrate impairments in pheno-
typic flexibility related to amino acid or nitrogen handling
in insulin resistance or diabetes when the metabolic system
is challenged with larger quantities of dietary protein.
Taken together, a high protein intake—whether acute or
chronic—has complex effects on the metabolic system. It
reduces the metabolic adaptation to insulin action, and
forces amino acids to be used as energy substrates thus
reducing the need to burn lipids and carbohydrates which
may promote insulin resistance and diabetes by their glu-
cotoxicity and lipotoxicity. In addition, increased gluco-
neogenesis in insulin-resistant state further enhances
hyperglycemia. The need for elimination of the nitrogen
surplus challenges hepatic urea production and the renal
elimination. In addition, sulfur derived from methionine
and cysteine intake challenges the acid–base balance.
Conclusion and perspective
The above examples of carbohydrate (glucose), lipid (tri-
glycerides and fatty acids) and protein related phenotypic
flexibility all trigger acute and complex stress response
mechanisms of which optimal functioning is essential for
maintenance of metabolic health. Quantification of aspects
of these stress response reactions is informative on health
status and can be exploited as ‘‘biomarker of health.’’ In this
sense, the OGTT is well established and discussed above,
but research on triglycerides (Blaak et al. 2006; Krug et al.
2012; Musso et al. 2009), protein (Fernandes and van de
Kamer 1968; Bosch et al. 1984) and various combinations
of glucose, triglycerides and proteins, either as mixture of
the pure components (Pellis et al. 2011; Wopereis et al.
2013) or as mixed meal challenges (Phillips et al. 2010; van
Dijk et al. 2012) has been published. Also, mathematical
methods to analyze the stress response curves are being
developed (Vis et al. 2014). Each of these ‘‘stress tests’’ has
pro’s and con’s in terms of practical use vs value for
mechanistic interpretation. Apart from the OGTT, the
‘‘standardized phenotypic flexibility assay’’ now emerges as
75 g of glucose, 60 g of Palm oil and 30 g of protein.
All of these acute response reactions illustrate a number
of characteristics of phenotypic flexibility:
1. All processes result from an acute perturbation and
show a time course of stress response in the hour scale,
at first glance simple (‘‘glucose curve’’) but intrinsi-
cally complicated, spanning major parts of metabolic-
inflammatory control;
2. All processes are interdependent and can act via
multiple connections and feedback mechanisms;
3. Failure of a specific process in this phenotypic
flexibility network may be compensated by other
processes, but eventually lead to harmful adaptive
processes;
4. Interestingly, the ‘‘site of failure’’ does not need to be
the site of emerging pathology. Impaired adipose
expandability will result in ectopic lipid, inflammation
and hepatic/vascular disease.
5. Quantification of the molecular stress response reac-
tions after a standardized metabolic/caloric perturba-
tion such as the OGTT (Krug et al. 2012), standardized
mixed meal challenges (Pellis et al. 2011) or even Big
Macs (Bondia-Pons et al. 2014) (e.g., by plasma
metabolomics) reveals a detailed picture of the events
and can be used as biomarker and diagnostics of
phenotypic flexibility.
In contemplating health from a phenotypic flexibility
systems perspective, prevention of disease onset and the
role of diet in maintaining health become tangible and
concrete as many nutrients play a crucial role in the
mechanisms underlying the response pathways. For
example, dietary factors such as fructose but also betaine,
choline, carnitine and others play an important role both in
onset and prevention of fatty liver (de Wit et al. 2012;
Malaguarnera et al. 2010; Noland et al. 2009; Rutlegde and
Adeli 2007; Fischer et al. 2010). Oxidative stress and
inflammatory stress responses also rely on diet-derived
factors such as the eicosanoids as products of essential fatty
acids (Wopereis et al. 2013). We now realize that, in
general, dietary factors have roles that are mirror images of
those provided by drugs: The first optimize and facilitate
processes (salutogenesis, health promotion), while the lat-
ter mainly inhibit processes (disease management), which
by definition does not match with the concept of
strengthening or improving phenotypic flexibility.
Finally, we would like to emphasize that phenotypic
flexibility as defined above is embedded in a larger system.
It is part of a much wider flexibility system determining
and maintaining optimal health, which can only be
understood by integrating physiology and psychology, and
also taking into account the social environment. This bio-
psychological domain focuses on psycho-neuro-endocri-
nology instead of neuro-endocrinology alone. Visceral
adiposity is not only associated with a blunted metabolic
flexibility, but also with reduced flexibility in neuroendo-
crine and cognitive responses (Jones et al. 2012). From the
psychological perspective, the relationship with metabolic/
inflammatory health is becoming apparent. For example,
social support is related to changes in cardiovascular,
neuroendocrine and immune function, optimism has been
Genes Nutr (2014) 9:423 Page 7 of 9 423
123
associated with immune up-regulation, and adaptive coping
is linked with reduced cortisol output (see (Steptoe et al.
2009) and references). Here, the well-known concept in
psychology of resilience nicely aligns with phenotypic
flexibility.
Secondly, flexibility has different time dimensions. As
described above, phenotypic flexibility responses to acute
challenges occur with timescales of minutes to hours while
chronic adaptation processes and allostatic processes, as
the consequence of all efforts to maintain homeostasis and
flexibility that result in pathologies, usually span months to
decades. Some of these adaptive processes and their health
consequences have already been mentioned above.
The emphasis for life science research has to be aligned
with the improved insights related to the new concepts and
definitions of health. Studies need to focus more on system
response monitoring, measuring the dynamics of regulatory
processes in a much broader context.
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